Details of Disease

Disease Name

Retina venous occlusion

Disease Class

9B74: Retinal vascular occlusion

Disease Hierarchy

DIS01GPL: Grass pollen hypersensitivity

DISMU050: Retina venous occlusion

ICD-11

ICD-11: 9B74.1

Expand ICD-11

'9B74.1

Disease Identifiers

MONDO ID

MONDO_0006951

MESH ID

D012170

UMLS CUI

C0035328

MedGen ID

19763

HPO ID

HP:0012636

SNOMED CT ID

1237532002

General Information of Disease (ID: DISMU050)

Drug-Interaction Atlas (DIA) of This Disease

Drug-Interaction Atlas (DIA)

This Disease is Treated as An Indication in 1 Approved Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
Ecallantide	DMOF2C6	Approved	Small molecular drug	[1]
------------------------------------------------------------------------------------

This Disease is Treated as An Indication in 1 Clinical Trial Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
AGN-208397	DMHZUF8	Phase 1/2	NA	[2]
------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)

References

1	URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6955).
2	ClinicalTrials.gov (NCT01027650) Safety and Efficacy of AGN208397 in the Treatment of Macular Edema Associated With Retinal Vein Occlusion (RVO). U.S. National Institutes of Health.